Narwhal Capital Management Eli Lilly & CO Transaction History

Narwhal Capital Management

$1.09 Billion
Q3 2024

A detailed history of Narwhal Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Narwhal Capital Management holds 21,403 shares of LLY stock, worth $17 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares

21,403

Previous 17,996 18.93%

Holding current value

$17 Million

Previous $16.3 Million 16.38%

% of portfolio

1.73%

Previous 1.56%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$772.14 - $960.02 $2.63 Million - $3.27 Million	3,407 Added 18.93%	21,403 $19 Million
Q2 2024 Aug 05, 2024	BUY	$724.87 - $909.04 $1.32 Million - $1.66 Million	1,821 Added 11.26%	17,996 $16.3 Million
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $1.64 Million - $2.19 Million	-2,764 Reduced 14.59%	16,175 $12.6 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $331,920 - $391,290	-632 Reduced 3.23%	18,939 $11 Million
Q3 2023 Oct 27, 2023	SELL	$434.7 - $599.3 $1.09 Million - $1.5 Million	-2,500 Reduced 11.33%	19,571 $10.5 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $1.38 Million - $1.85 Million	-3,935 Reduced 15.13%	22,071 $10.4 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $1.76 Million - $2.07 Million	5,675 Added 27.91%	26,006 $8.93 Million
Q4 2022 Jan 30, 2023	BUY	$321.55 - $374.67 $1.01 Million - $1.17 Million	3,133 Added 18.22%	20,331 $7.44 Million
Q3 2022 Oct 31, 2022	BUY	$296.48 - $337.87 $4.84 Million - $5.52 Million	16,340 Added 1904.43%	17,198 $5.56 Million
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $53,978 - $67,081	-230 Reduced 21.14%	858 $246,000
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $34,626 - $42,972	-154 Reduced 12.4%	1,088 $301,000
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $224,243 - $290,056	1,242 New	1,242 $285,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.

Account

Narwhal Capital Management Eli Lilly & CO Transaction History